Verastem (VSTM) Q3 2026 Earnings Call Transcript
Pancreatic data and a planned Phase III launch highlighted the call.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.